Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study

Abstract Background Hemadsorption of cytokines is used in critically ill patients with sepsis or septic shock. Concerns have been raised that the cytokine adsorber CytoSorb® unintentionally adsorbs vancomycin. This study aimed to quantify vancomycin elimination by CytoSorb®. Methods Critically ill p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Christina Scharf, Ferdinand Weinelt, Ines Schroeder, Michael Paal, Michael Weigand, Michael Zoller, Michael Irlbeck, Charlotte Kloft, Josef Briegel, Uwe Liebchen
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-05-01
Col·lecció:	Annals of Intensive Care
Matèries:	Vancomycin Critically ill patients CytoSorb® Sepsis Pharmacokinetics Adsorption
Accés en línia:	https://doi.org/10.1186/s13613-022-01017-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!